Is the new WHO definition of extensively drug-resistant tuberculosis easy to apply in practice?
- PMID: 34215664
- DOI: 10.1183/13993003.00959-2021
Is the new WHO definition of extensively drug-resistant tuberculosis easy to apply in practice?
Conflict of interest statement
Conflict of interest: R. Alagna has nothing to disclose. Conflict of interest: A.M. Cabibbe has nothing to disclose. Conflict of interest: P. Miotto has nothing to disclose. Conflict of interest: F. Saluzzo has nothing to disclose. Conflict of interest: C.U. Köser is a consultant for Becton Dickinson, the Foundation for Innovative New Diagnostics, the Stop TB Partnership and the TB Alliance; has worked as a consultant for QuantuMDx, the World Health Organization (WHO) Global TB Programme, and WHO Regional Office for Europe; gave a paid educational talk for Oxford Immunotec; had travel and accommodation expensed covered by Hain Lifescience to present at a meeting; and is an unpaid advisor to BioVersys and GenoScreen. Conflict of interest: S. Niemann has nothing to disclose. Conflict of interest: S. Gagneux has nothing to disclose. Conflict of interest: C. Rodrigues has nothing to disclose. Conflict of interest: P.M.V. Rancoita has nothing to disclose. Conflict of interest: D.M. Cirillo has nothing to disclose.
Comment on
-
New definitions of pre-extensively and extensively drug-resistant tuberculosis: update from the World Health Organization.Eur Respir J. 2021 Apr 8;57(4):2100361. doi: 10.1183/13993003.00361-2021. Print 2021 Apr. Eur Respir J. 2021. PMID: 33833074 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources